Simmons & Simmons’ Post

🚀 Health Tech's Missing Piece: The 51% Solution 👩💼💉 Did you know? Women make 80% of healthcare decisions but remain underrepresented in health tech leadership. It's time to change that! Join us for a masterclass on investing in women-led health tech innovations with industry leaders: 🌟 Aahuti Rai (Four Points Consulting Ltd) 🌟 Bridget Gorham (NHS Confederation) 🔗 Register now: https://lnkd.in/evnWpFn5 We'll explore: ✅ Redesigning investment strategies for women-led ventures ✅ Unique innovations in femtech and personalized medicine ✅ Impact of inclusive digital health solutions Question: What women-led health tech innovation excites you most? Share below! #WomenInHealthTech #FemTech #HealthcareInnovation #HLTH

🌟 #FemTech: Empowering Health Choices 🌟 Insights into how FemTech innovations are revolutionising women's healthcare, promoting equity and accessibility! Check out the article where Lavinia Pamparau, NHS Navigator for DigitalHealth.London, explores the transformative potential of FemTech solutions to address long-standing inequalities and empower women to take control of their health. 🔍 Key Takeaways: ✅ FemTech startups such as Ellescope and Bloomful are driving innovation with tailored solutions for women's health needs. ✅ Collaboration between the NHS, academia, policymakers, and industry is essential to drive FemTech adoption. ✅ Efforts are underway to increase awareness, representation, and investment in FemTech to support entrepreneurs and improve access to healthcare. ✅ Let's champion FemTech as a vital tool in closing the gap in women's healthcare access and outcomes! Read the full article here https://lnkd.in/dQQPKsBf #FemTechRevolution #WomenInHealth #HealthTech #DigitalHealth

Accenture + Springboard Enterprises recently released the "State of Women's Health" report, which examines the current status of women's health and emphasizes critical areas where innovation and funding are urgently required. Take a sneak peek at some data here: -Only 5% of medicines approved by the FDA in 2022 were for female-specific conditions. -In 2023, only $1.1 billion of the $26.5 billion VC capital invested in healthcare went to women's health companies, despite a 59% increase from the previous year. -The budget for the NIH Office for Research on Women’s Health increased by only 9.7% over 17 years, from $41 million in 2003 to $45 million in 2020. We are also proud to see our portfolio company AOA Dx featured as a change maker in the space! 👏

#4: The FemTech leaders of 2024 will offer an integrated, end-to-end care pathway for women “The winners in this space will be those that can position themselves as orchestrators of the emerging ecosystems – using data effectively to personalise the patient experience and thoughtfully integrating with chosen partners.” Discover key insights from Boston Consulting Group (BCG)’s The Future of Digital Health 2024 report in the latest issue of INNOVATION! Read it now 👉 https://lnkd.in/eRkcCPYN

💡 Despite a tough economic climate, 2023 has been a standout year for #FemTech investment! 📈 Bold investors are recognizing the untapped potential in women's health, with major funding rounds fueling the future of healthcare. From Kindbody's $100M to Midi Health's $25M, we're on the brink of a health revolution! 💪 Join us in celebrating this milestone and stay tuned for the innovations set to change the game. 🔗Click the link below to download the full FemTech Landscape Report 2023 from FemHealth Insights and join us in redefining women's health through technology 🔗 https://loom.ly/MoA7Z6k #FemTech2023 #WomensHealthInnovation #HealthTech

🌍🩺✨MedTech, it's time to tune into women's health. As we witness a surge in 🚀investment and groundbreaking initiatives like the White House's stance on Women's Health Research, the future is clear - we're on the brink of a transformation. The narrative is shifting, from a "one-size-fits-all" to bespoke healthcare pathways tailored for women. Gone are the days where women's health takes the backseat, as industries rally to address diseases like endometriosis and PCOS that have lingered in the shadows, undiagnosed or misdiagnosed for too long.🔬 Digital innovation spells a new dawn for MedTech pioneers. With digital solutions becoming more intertwined with patient care, MedTech companies with savvy, digital-fluent capabilities are set to lead this evolution. 📲🩺 We're seeing consumer products morph into FDA-approved medical devices, opening doors and shattering ceilings in women's healthcare. Companies like Mosie Baby exemplify the journey from a home-use product to a recognized medical device, illustrating the emerging consumer-product-to-medical-device trajectory. Inclusion isn't just a buzzword; it's the keystone in our portfolio. Driving DEI forward, it's tangible in the balanced and sensitive approach to treatment for all. 💼🌈 Collaboration is key. Traditional giants, startups, and investors are joining forces like never before to forge new pathways in women's health. 🤝 For decision makers in HealthTech, Biotech and Pharma: let's align our executive vision with these transformative times. And for my executive peers in tech, the moment to impact women's health is here. Let's drive change together. #MedTech #WomensHealth #Innovation

💡 Despite a tough economic climate, 2023 has been a standout year for #FemTech investment! 📈 Bold investors are recognizing the untapped potential in women's health, with major funding rounds fueling the future of healthcare. From Kindbody's $100M to Midi Health's $25M, we're on the brink of a health revolution! 💪 Join us in celebrating this milestone and stay tuned for the innovations set to change the game. 🔗Click the link below to download the full FemTech Landscape Report 2023 from FemHealth Insights and join us in redefining women's health through technology 🔗 https://loom.ly/MoA7Z6k #FemTech2023 #WomensHealthInnovation #HealthTech

Which of these has gotten more attention, ink, and investment? If the people who develop and invest in innovation and technology have influence over the problems we’re solving, then it only makes sense that men’s health issues have gotten far more attention, study and investment than women’s. The emergence of FemTech is starting to change that and starting to shine a light on some important facts. Like the fact that: - Diseases present differently in women than in men. - Historically, clinical trials have excluded female participants and research data have been collected from males and generalized to females.  - Data gaps underestimate women’s health burden, limiting innovation and investment. - The ranks of female leaders in healthcare and in tech are thin, and some reports indicate we may be seeing a regression of some of the recent progress that’s been made. - FemTech is helping to match capital and talent to unmet needs. Visana Health Co-Founder and President Shelly Lanning, Flare Capital Partners Principal Margaret Malone, and former Guidewell Venture Group Chief Commercial Officer Leigh Ann Ruggles talk openly about this and more on our latest podcast. Have a listen with the link in our comments. #FemTech #WomenInTech #HealthcareInnovation

Happening today on stage at #CES: How tech can transform women's health Nest Health Founder & CEO, Rebekah Gee MD MPH, joins leaders from Consumer Technology Association, Wisp, BioIntelliSense, Inc, and HIT Like a Girl Pod to explore how healthcare innovation is changing how we address women’s health needs and improving outcomes. #futureofhealthcare #womenshealth #CES2024